[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335291-105":59,"doc-detail-335291-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","hpv-and-penile-cancer-epidemiology-risk-factors-and-clinical-insights","HPV and Penile Cancer - Epidemiology, Risk Factors, and Clinical Insights","","Penile cancer is a rare malignancy predominantly of squamous cell origin, with about 40% of penile tumors linked to human papillomavirus infection. Clinical diagnosis is difficult due to rarity and diverse presentations, while HPV-driven effects on the tumor immune microenvironment further complicate management. Recent progress with immune checkpoint inhibitors shows limited efficacy for HPV-associated disease. Emerging directions include HPV-modification targeted oncologic strategies and therapies such as vaccines and adoptive T cells against HPV oncoproteins.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/hpv-and-penile-cancer-epidemiology-risk-factors-and-clinical-insights/335291/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/hpv-and-penile-cancer-epidemiology-risk-factors-and-clinical-insights/335291.png","ImageObject",300,407,{"name":92,"@type":93},"Miles","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How common is HPV involvement in penile cancer?","Question",{"text":112,"@type":113},"Approximately 40% of penile tumors are associated with human papillomavirus infection.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Why is diagnosing penile cancer considered challenging?",{"text":117,"@type":113},"Diagnosis remains challenging because penile cancer is rare and has a variety of clinical presentations.",{"name":119,"@type":110,"acceptedAnswer":120},"What emerging treatments are highlighted for HPV-associated penile cancer?",{"text":121,"@type":113},"The review emphasizes immune checkpoint inhibitors and emerging approaches such as novel therapeutic vaccines and adoptive T-cell therapies targeting HPV oncoproteins.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335291,1790193612,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","pathogens   \nReview  \nHPV and Penile Cancer: Epidemiology, Risk Factors, and Clinical Insights  \nGowtam Mannam 1,†, Justin W. Miller 1,†, Jeffrey S. Johnson 2, Keerthi Gullapalli 2, Adnan Fazili 2, Philippe E. Spiess 2 and Jad Chahoud 2, *  \nCitation: Mannam, G.; Miller, J.W.; Johnson, J.S.; Gullapalli, K.; Fazili, A.; Spiess, P.E.; Chahoud, J. HPV and Penile Cancer: Epidemiology, Risk Factors, and Clinical Insights. Pathogens 2024, 13, 809. [https://](https://)[ ](https://)[doi.org/10.3390/pathogens13090809](doi.org/10.3390/pathogens13090809)  \nAcademic Editor: Ramona Gabriela Ursu  \nReceived: 13 August 2024  \nRevised: 13 September 2024  \nAccepted: 17 September 2024  \nPublished: 18 September 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 USF Health Morsani College of Medicine, Tampa, FL 33602, USA; [gmannam@usf.edu](gmannam@usf.edu) (G.M.); [justinmiller1@usf.edu](justinmiller1@usf.edu) (J.W.M.)  \n2 Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA; jeff.johnson@moffitt.org (J.S.J.); keerthi.gullapalli@moffitt.org (K.G.); adnan.fazili@moffitt.org (A.F.); philippe.spiess@moffitt.org (P.E.S.)  \n* [Correspondence: jad.chahoud@moffitt.org](Correspondence: jad.chahoud@moffitt.org); Tel.: +1-813-745-6926 † These authors contributed equally to this work.  \nAbstract: Penile cancer (PC) is a rare malignancy predominantly of squamous cell origin. Approximately 40% of penile tumors are associated with human papillomavirus (HPV) infection. Diagnosing PC remains challenging due to its rarity and variety of clinical presentations. Furthermore, the impact of HPV on the tumor immune microenvironment complicates clinical management, although recent advancements in immune checkpoint inhibitors (ICIs) have shown some efficacy in treating HPV-associated PC. Ongoing research efforts aim to develop oncologic treatments that target HPVinduced cellular modifications. Additionally, novel therapeutic vaccines and adoptive T-cell therapies targeting HPV oncoproteins represent emerging treatment modalities. Our review highlights the complex interplay between HPV and penile carcinogenesis, emphasizing its epidemiology, etiology, clinicopathological characteristics, and potential therapeutic implications.  \nKeywords: human papillomavirus; HPV; penile cancer; penile tumor; PSCC; immunotherapy; tumor immune microenvironment  \n1. Introduction  \nPenile cancer (PC) is a rare malignancy of penile tissues. The estimated age-standardized incidence rate (ASR) of PC in 2020 was 0.8 per 100,000 globally, with higher rates in South America, Southern Africa, and South Asia, where incidence can account for up to 10% of malignancies [1,2] . In the United States, the incidence of PC is 0.38 per 100,000 with a mean age of 67 [2,3] . Most penile cancers are of squamous cell origin with frequent association with the human papillomavirus (HPV) [4] . Consequently, penile squamous cell carcinoma (PSCC) is generally classified as being either HPV-associated or HPV-independent. Other risk factors include phimosis, tobacco use, poor hygiene, sexual promiscuity, and a low socioeconomic status [5] . HPV-associated penile cancers account for 38.5% of cases, with the HPV 16 serotype being the most common [6] . Despite tumor size, invasion, nodal involvement, and the presence of metastases being the primary prognostic factors, knowledge of HPV pathogenesis provides a strong target for PC treatment [7,8] . In this review, we aim to provide an overview of HPV-associated penile cancer to summarize its clinicopathological characteristics and emerging clinical applications targeting HPV.  \n2. Morphology, Epidemio","cbCaikxSaoa36W19","https://ap.wps.com/l/cbCaikxSaoa36W19","pdf",309015,14,"English","# Introduction\n## Morphology, Epidemiology, and Risk Factors of Penile Cancer","[{\"question\":\"How common is HPV involvement in penile cancer?\",\"answer\":\"Approximately 40% of penile tumors are associated with human papillomavirus infection.\"},{\"question\":\"Why is diagnosing penile cancer considered challenging?\",\"answer\":\"Diagnosis remains challenging because penile cancer is rare and has a variety of clinical presentations.\"},{\"question\":\"What emerging treatments are highlighted for HPV-associated penile cancer?\",\"answer\":\"The review emphasizes immune checkpoint inhibitors and emerging approaches such as novel therapeutic vaccines and adoptive T-cell therapies targeting HPV oncoproteins.\"}]","HPV and Penile Cancer - Epidemiology, Risk Factors, and Clinical Insights | PDF",1790010405,35]